116 related articles for article (PubMed ID: 1671164)
21. Pituitary glycoprotein hormone alpha-subunit secretion after thyrotropin-releasing hormone stimulation in normal men and men with idiopathic hypogonadotropic hypogonadism.
Winters SJ; Troen P
J Clin Endocrinol Metab; 1990 Feb; 70(2):544-7. PubMed ID: 1688869
[TBL] [Abstract][Full Text] [Related]
22. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
[TBL] [Abstract][Full Text] [Related]
23. Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus.
Djursing H; Hagen C; Nyholm HC; Carstensen L; Andersen AN
J Clin Endocrinol Metab; 1983 May; 56(5):1016-21. PubMed ID: 6403566
[TBL] [Abstract][Full Text] [Related]
24. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists.
Hall JE; Whitcomb RW; Rivier JE; Vale WW; Crowley WF
J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329
[TBL] [Abstract][Full Text] [Related]
26. Calcium antagonists and hormone release. II. Effects of verapamil on basal, gonadotropin-releasing hormone- and thyrotropin-releasing hormone-induced pituitary hormone release in normal subjects.
Barbarino A; De Marinis L
J Clin Endocrinol Metab; 1980 Oct; 51(4):749-53. PubMed ID: 6774993
[TBL] [Abstract][Full Text] [Related]
27. Selective dopamine-1 receptor agonist augments regional myocardial blood flow: comparison of fenoldopam and dopamine.
Shi Y; Zalewski A; Bravette B; Maroko AR; Maroko PR
Am Heart J; 1992 Aug; 124(2):418-23. PubMed ID: 1353297
[TBL] [Abstract][Full Text] [Related]
28. Effect of dopamine on renal blood flow, prostaglandins, renin and electrolyte excretion in normal and hypertensive humans.
Horton R; Bughi S; Jost-Vu E; Antonipillai I; Nadler J
Am J Hypertens; 1990 Jun; 3(6 Pt 2):108S-111S. PubMed ID: 1974438
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Na+,K(+)-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation.
Chen C; Lokhandwala MF
Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):289-95. PubMed ID: 8097567
[TBL] [Abstract][Full Text] [Related]
30. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
[TBL] [Abstract][Full Text] [Related]
31. Evidence of altered dopaminergic modulation of Prl, LH, FSH, GH and TSH secretion during chronic partial dopamine receptor blockade in normal women.
Hagen C; Andersen AN; Djursing H
Acta Endocrinol (Copenh); 1984 May; 106(1):1-7. PubMed ID: 6428112
[TBL] [Abstract][Full Text] [Related]
32. Pituitary glycoprotein hormones in chronic renal failure: evidence for an uncontrolled alpha-subunit release.
Medri G; Carella C; Padmanabhan V; Rossi CM; Amato G; De Santo NG; Beitins IZ; Beck-Peccoz P
J Endocrinol Invest; 1993 Mar; 16(3):169-74. PubMed ID: 7685785
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular responses in healthy subjects to a novel oral dopamine agonist, fenoldopam.
Cregeen RJ; Rudge PJ; Mills JG; Vincent SH; Burland WL
J Hypertens Suppl; 1985 Dec; 3(3):S173-5. PubMed ID: 2908814
[TBL] [Abstract][Full Text] [Related]
34. Long-term effects of a gonadotrophin-releasing hormone agonist ([D-Ser(But)6]GnRH(1-9)nonapeptide-ethylamide) on gonadotrophin secretion from human pituitary gonadotroph cell adenomas in vitro.
Daniels M; Newland P; Dunn J; Kendall-Taylor P; White MC
J Endocrinol; 1988 Sep; 118(3):491-6. PubMed ID: 2460576
[TBL] [Abstract][Full Text] [Related]
35. Effects of fenoldopam on alpha-methyl-p-tyrosine-stimulated prolactin secretion in conscious rats.
Schoors DF; Dupont AG
Eur J Pharmacol; 1989 Nov; 173(1):109-12. PubMed ID: 2575038
[TBL] [Abstract][Full Text] [Related]
36. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
Grenader A; Healy DP
J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
[TBL] [Abstract][Full Text] [Related]
37. Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin beta-subunit genes in normal and castrated rat pituitary.
Lerrant Y; Kottler ML; Bergametti F; Moumni M; Blumberg-Tick J; Counis R
Endocrinology; 1995 Jul; 136(7):2803-8. PubMed ID: 7789305
[TBL] [Abstract][Full Text] [Related]
38. Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH.
Jeppsson S; Nilsson KO; Rannevik G; Wide L
Acta Endocrinol (Copenh); 1976 Jun; 82(2):246-53. PubMed ID: 818858
[TBL] [Abstract][Full Text] [Related]
39. Human vasodilator responses to a dopamine agonist: possible mechanisms.
Redman D; Thom SA; Hughes AD; Hasan S; Sever PS
J Hypertens Suppl; 1985 Dec; 3(3):S177-8. PubMed ID: 2908815
[TBL] [Abstract][Full Text] [Related]
40. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea.
Giammartino C; Ambrosi F; Pelicci G; Pagliacci MC; Fedeli L; Nicoletti I
Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
